Softgel Capsules Market Size Worth $13.09 Billion By 2030

Softgel Capsules Market Growth & Trends

The global softgel capsules market size is estimated to reach USD 13.09 billion by 2030 registering a CAGR of 7.9%, according to a new report by Grand View Research, Inc. Softgel capsules are proven to be the choice of formulation for poorly soluble drugs and enhance the absorption time of most drug molecules. Its advantages over tablets and other oral formulations have led to the increased adoption of softgel capsules across the globe. Ease of swallowing, taste masking, improved bioavailability, non-reactive, aesthetically appealing, and longer shelf life are the factors influencing its wide acceptance.

Leading players like Catalent, Eurocaps, and many others, are developing vegan capsules to broaden their vegan consumer base as the softgel capsule segment registers nearly 40% of their overall revenue. Large Pharma companies like Pfizer, Novartis, Bayer, and Procter and Gamble, collaborate with leading Contract Manufacturing Organizations (CMO) to provide cost-effective products in the highly competitive market. Research to develop an oral vaccine to treat respiratory infection caused by the SaRS-CoV-2 virus has fueled the R&D of softgel manufacturers. Additionally, the shift towards a healthier lifestyle and immunity-boosting vitamins, have also surged the softgel market post the outbreak of the COVID-19 pandemic. 

 Request a free sample copy or view report summary: Softgel Capsules Market Report

Softgel Capsules Market Report Highlights

• The gelatin segment accounted for the largest revenue share in 2021 in the type outlook due to its advantages over any other excipient in the excipient industry

• Nutraceutical companies held the largest revenue-generating segment by manufacturers, owing to the increasing awareness of health supplements among developing nations and the growing number of production houses, and the surge in sales due to the COVID-19 pandemic

• North America held the largest share in the market due to the Improved production technology, presence of major players within the region, and increased expenditure on R&D to widen their product portfolio

Softgel Capsules Market Segmentation

Grand View Research has segmented the softgel capsules market based on type, application, manufacturer, and region:

Softgel Capsules Type Outlook (Revenue, USD Million, 2017 - 2030)

• Gelatin/ Animal-Based

• Non-animal Based

Softgel Capsules Application Outlook (Revenue, USD Million, 2017 - 2030)

• Antacid & Anti-flatulent Preparations

• Anti-anemic Preparations

• Anti-inflammatory Drugs

• Antibiotic & Antibacterial Drugs

• Cough & Cold Preparations

• Health Supplement

• Vitamin & Dietary Supplement

• Pregnancy

Softgel Capsules Manufacturers Outlook (Revenue, USD Million, 2017 - 2030)

• Pharmaceutical Companies

• Nutraceutical Companies

• Cosmeceutical Companies

• Contract Manufacturing Organizations

Softgel Capsules Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • U.K.

  • France

  • Italy

  • Spain

  • Norway

  • Sweden

  • Russia

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • Turkey

  • UAE

List of Key Players in Softgel Capsules Market

•  Fuji Capsules Co Ltd

•  Sirio Pharma

• Captek

• Patheon

• Catalent

• Eurocaps

• Aenova

• Capsugel

• Procaps Laboratories

• Soft Gel Technologies Inc.